Neuros Medical has received notification of award for $1.5m from the US Department of Defense. The Applied Research and Technology Development funding provided by the Defense Medical Research and Development Program (DMRDP) is expected to aid technology development and human clinical research for neurostimulation therapy.

Neuros Medical said that the stimulation therapy, Nerve Block, focuses on the treatment of chronic residual limb pain which is suffered by nearly one million amputees.

Neuros Medical’s technology utilises high frequency alternating current stimulation to block chronic pain signals in the peripheral nervous system.

In addition, military casualties and amputations experienced by those serving in Iraq and Afghanistan have contributed to the need to develop effective treatments for patients suffering from chronic residual limb pain.

Jon Snyder, president and CEO of Neuros Medical, said: “The US Military holds a strong commitment to continued care for the wounded warrior, even after the battlefield experience. Our efforts via this funding will greatly advance our technology’s application in providing a proven treatment for patients with chronic pain, specifically residual limb pain.”